Annals of Diagnostic Pathology
Volume 13, Issue 2 , Pages 82-88 , April 2009

Expression of epithelial cell adhesion molecule and pituitary tumor transforming gene in adamantinomatous craniopharyngioma and its correlation with recurrence of the tumor

  • Martha Lilia Tena-Suck, MD

      Affiliations

    • Departamento de Neuropatología, Instituto Nacional de Neurología y Neurocirugía, México City, México
    • Corresponding Author InformationCorresponding author. Departamento de Neuropatología, Instituto Nacional de Neurología y Neurocirugía “Manuel Velasco Suárez,” Av Insurgentes Sur 3788 Col. La Fama, Tlalpan cp. 14269, México, DF, México. Tel.: +52 5 56063822x2008.
    • ,
  • Alma Ortiz-Plata, PhD

      Affiliations

    • Departamento de Neuropatología, Instituto Nacional de Neurología y Neurocirugía, México City, México
    • ,
  • Francisco Galán, MD, PhD

      Affiliations

    • Torre de Investigación Farmacológica, Hospital Médica Sur, Mexico City, Mexico
    • ,
  • Aurora Sánchez, Bsc

      Affiliations

    • Departamento de Neuropatología, Instituto Nacional de Neurología y Neurocirugía, México City, México

References 

  1. Van Effenterre R, Boch AL. Craniopharyngioma in adults and children: a study of 122 surgical cases. J Neurosurg. 2002;97:3–11
  2. Weiner HL, Wisoff JH, Rosenberg ME, Kupersmith MJ, Cohen H, Zagzag D, et al. Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery. 1994;35:1001–1010
  3. Janzer RC, Berger PC, Giangaspero F, Paulus W. In:  Keihues P,  Cavenee WK editor. Tumors of the nervous system, pathology & genetics. World Health Organization classification of tumors. Chapter: tumors of the sellar region. Lyon, France: IARC Press; 2000;p. 244–246
  4. Uematsu Y, Tanaka Y, Matsumoto H, Funahashi K, Itakura T, Komai N. Histological analysis of craniopharyngiomas with special reference to their histological origin and differentiation. No To Shinkei. 1994;46:271–276
  5. Balzar M, Winter MJ, de Boer CJ, et al. The biology of the 17-IA antigen (EpCAM). J Mol Med. 1999;77:699–712
  6. Munz M, Kieu C, Mack B, Schmitt B, Zeidler R, Gires O. The carcinoma associated antigen EpCAM up-regulates c-myc and induces cell proliferation. Oncogene. 2004;23:5748–5758
  7. Went PT, Lugli A, Meier S, Bundi M, Mirlacher M, Sauter G, et al. Frequent Ep-CAM protein expression in human carcinomas. Hum Pathol. 2004;35:122–128
  8. Piyathilake CI, Frost AR, Weiss H, et al. The expression of Ep-CAM in squamous cell cancer of the lung. Hum Pathol. 2000;31:482–487
  9. Osta WA, Chen Y, Mikhitarian K, Mitas M, Salem M, Hannun YA, et al. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res. 2004;64:5818–5824
  10. Yu R, Melmed S. Oncogene activation in pituitary tumors. Brain Pathol. 2001;11:328–341
  11. Yu R, Melmed S. Pituitary tumor transforming gene: an update. Front Horm Res. 2004;32:175–185
  12. Musat M, Vax VV, Borboli N, Gueorguiev M, Bonner S, Korbonits M, et al. Cell cycle dysregulation in pituitary oncogenesis. Front Horm Res. 2004;32:34–62
  13. Hamid T, Kakar SS. PTTG/securin activates expression of p53 and modulates its function. Mol Cancer. 2004;3:18–23
  14. Solbach C, Roller M, Fellbaum C, Nicoletti M, Kaufmann M. PTTG mRNA expression in primary breast cancer: a prognostic marker for lymph node invasion and tumor recurrence. Breast. 2004;13:80–81
  15. Mu YM, Oba K, Yanase T, Ito T, Ashida K, Goto K, et al. Human pituitary tumor transforming gene (hPTTG) inhibits human lung cancer A549 cell growth through activation of p21 (WAF1/CIP1). Endocr J. 2003;50:771–781
  16. Nishimoto A, Matsuhisa T, Kunishio K, et al. Craniopharyngioma: early and long term recurrence after partial removal. J Neurol Neurosurg Psychiatry. 1995;58:111–112
  17. Kim SK, Wang KC, Shin SH, et al. Radical excision of pediatric craniopharyngioma: recurrence pattern and prognostic factors. Childs Nerv Syst. 2001;17:531–536
  18. Kristopaitis T, Thomas C, Petruzzelli GJ, Lee JM. Malignant craniopharyngioma. Arch Pathol Lab Med. 2000;124:1356–1360
  19. Petito CK. Craniopharyngioma: prognostic importance of histologic features. AJNR Am J Neuroradiol. 1996;17:1441–1442
  20. Parate SN, Anshu , Helwatkar SB, Munsh MM. Cytology of recurrent ameloblastoma with malignant changes. Acta Cytol. 1999;43:1105–1107
  21. Sato K, Oka H, Utsuki S, Kondo K, Kurata A, Fujii K. Ciliated craniopharyngioma may arise from Rathke cleft cyst. Clin Neuropathol. 2006;25:25–28
  22. Luse SA, Kernohan JW. Squamous-cell nests of the pituitary gland. Cancer. 1955;8:623–628
  23. Asa SL. Tumors of the pituitary gland. In: Atlas of tumors of pathology. Bethesda (Md): Armed Forces Institute of Pathology; 2001;p. 167–176
  24. Scheithauer BW, Horvath E, Kovacs K, Lloyd RV, Stefaneanu L, Buchfelder M, et al. Prolactin-producing pituitary adenoma and carcinoma with neuronal components a metaplastic lesion. Pituitary. 1999;1:197–205
  25. Renner U, Pagotto U, Arzt E, Stalla GK. Autocrine and paracrine roles of polypeptide growth factors, cytokines and vasogenic substances in normal and tumorous pituitary function and growth: a review. Eur J Endocrinol. 1996;135:515–532
  26. Kato K, Nakatani Y, Kanno H, Inayama Y, Ijiri R, Nagahara N, et al. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. J Pathol. 2004;203:814–821
  27. Izumoto S, Suzuki T, Kinoshita M, Hashiba T, Kagawa N, Wada K, et al. Immunohistochemical detection of female sex hormone receptors in craniopharyngiomas: correlation with clinical and histologic features. Surg Neurol. 2005;63:520–525
  28. Tachibana O, Yamashima T, Yamashita J, Takabatake Y. Immunohistochemical expression of human chorionic gonadotropin and P-glycoprotein in human pituitary glands and craniopharyngiomas. J Neurosurg. 1994;80:79–84
  29. Uchino Y, Saeki N, Iwadate Y, Yasuda T, Konda S, Watanabe T, et al. Recurrence of sellar and suprasellar tumors in children treated with hGH-relation to immunohistochemical study on GH receptor. Endocr J. 2000;47:33–36

PII: S1092-9134(08)00138-X

doi: 10.1016/j.anndiagpath.2008.12.004

Annals of Diagnostic Pathology
Volume 13, Issue 2 , Pages 82-88 , April 2009

Article Tools

* Image Usage & Resolution